#RareDiseases",
LightNews LightNews
oxfordharrington.bsky.social
In a recent episode of the In Vivo podcast, Matthew Wood discusses why rare disease research and drug development are at a pivotal moment and what must change to unlock progress for the ~500 million people impacted by rare diseases.

🎧Listen now: shorturl.at/y88MR

#RareDiseases #DrugDevelopment
Podcast: “We Are On The Cusp Of A Real Revolution”: OHC Rare Disease Center Boosts Innovation
Matthew Wood, director and chief scientific officer at Oxford-Harrington Rare Disease Center, discusses the state of rare disease R&D, the evolving landscape of genomics and genetic therapies, and…
insights.citeline.com
January 5, 2026 at 4:54 PM
shubham83.bsky.social
🧠 Growing awareness of rare movement disorders is shaping treatment demand. 🔗 www.marketresearchfuture.com/reports/paro...
#Neurology #RareDiseases
Paroxysmal Choreoathetosis Market Size, Growth Report 2035
Paroxysmal Choreoathetosis Market projected to grow at 7.3% CAGR, reaching USD 0.559 Million by 2035, driving growth global trends, competitive industry analysis and outlook 2025-2035
www.marketresearchfuture.com
January 5, 2026 at 1:34 PM
shubham83.bsky.social
🧠 Advances in genetic research are improving care for hereditary neuropathies. 🔗 www.marketresearchfuture.com/reports/char...
#Neurology #RareDiseases
Charcot Marie Tooth Hereditary Neuropathy Market 2035 | MRFR
Charcot-Marie-Tooth Hereditary Neuropathy Market growth is projected to reach USD 6.72 Billion, at a 6.94% CAGR by driving industry size, share, top company analysis, segments research, trends and for...
www.marketresearchfuture.com
January 5, 2026 at 1:34 PM
shubham83.bsky.social
👁️ Growing awareness of autoimmune eye disorders is shaping this rare disease market. 🔗 www.marketresearchfuture.com/reports/vogt...
#Ophthalmology #RareDiseases
January 5, 2026 at 1:34 PM
shubham83.bsky.social
🧬 Advancements in rare neuroendocrine tumor research are shaping the Vasoactive Intestinal Peptide Tumor Market. 🔗 www.marketresearchfuture.com/reports/vaso...
#RareDiseases #Oncology #MarketResearch
Vasoactive Intestinal Peptide Tumor Market Size, Share, Growth 2035
Vasoactive Intestinal Peptide Tumor Market growth is projected to reach USD 1.72 Billion, at a 4.76% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast ...
www.marketresearchfuture.com
January 5, 2026 at 1:34 PM
thezebraalliance.bsky.social
Yes, please 🤗😉

#healthmemes
linktr.ee/thezebraalliance
#meme #memes #jokes #chronicillness #EDS #rarediseases #invisibleillness #disability #dynamicdisability #ehlersdanlossyndrome
A weighted blanket is not enough I need to be compressed into a .zip file
January 5, 2026 at 12:40 AM
thezebraalliance.bsky.social
Feel this deep in our souls. How about you? 🫠🤪😉

#healthmemes #meme #memes #jokes #chronicillness #EDS #rarediseases #invisibleillness #disability #dynamicdisability
January 4, 2026 at 3:19 PM
drtimos.bsky.social
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TQ7fPy #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
January 3, 2026 at 4:00 PM
thezebraalliance.bsky.social
If you know, you know. 🚑
And its even worse if youre Canadian. Just kidding! ... sort of 😅😉

#healthmemes
linktr.ee/thezebraalliance
#portlandia #meme #memes #jokes #chronicillness #EDS #rarediseases #invisibleillness #disability #dynamicdisability #mentalhealth
When youre having a health emergency but still trying not to be a burden: "Hello 911? How are you?" (From the show, Portlandia)
January 3, 2026 at 3:30 PM
yuvip.bsky.social
🧴 Fox-Fordyce Disease Treatment focuses on managing rare skin conditions. 🌿📊 www.marketresearchfuture.com/reports/foxf... #Dermatology #RareDiseases #Healthcare
Foxfordyce Disease Treatment Market Size, Therapeutics 2035
Foxfordyce Disease Treatment Market size is expected to grow at a 4.01% CAGR from 2024, 225.05 Billion USD to 346.9 Billion USD by 2035. Foxfordyce Disease Treatment Industry Analysis by Types, Applic...
www.marketresearchfuture.com
January 3, 2026 at 11:55 AM
yuvip.bsky.social
🧠 Canavan Disease Treatment research is shaping future neurological therapies. 🔬📊 www.marketresearchfuture.com/reports/cana... #Neurology #RareDiseases #MedicalInnovation
Canavan Disease Treatment Market Size, Share, Trends Forecast 2035
Canavan Disease Treatment Market growth is projected to reach USD 281.23 Billion, at a 3.49% CAGR by driving industry, top company analysis, segments research, trends and forecast report 2025 to 2035
www.marketresearchfuture.com
January 3, 2026 at 11:54 AM
yuvip.bsky.social
🩸 Calcify Uremic Arteriolopathy drug development addresses severe kidney-related complications. 🩺📈 www.marketresearchfuture.com/reports/calc... #Nephrology #RareDiseases #DrugDevelopment
Calcify Uremic Arteriolopathy Drug Market Report 2035
Calcify Uremic Arteriolopathy Drug Market growth is projected to reach USD 5.76 Billion, at a 4.85% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast r...
www.marketresearchfuture.com
January 3, 2026 at 11:54 AM
yuvip.bsky.social
🧬 Buschke–Ollendorff Syndrome research supports better rare disease understanding. 🔍📊 www.marketresearchfuture.com/reports/busc... #RareDiseases #MedicalGenetics #Healthcare
Buschke-Ollendorff Syndrome Market Size, Share, Trends, 2035
Buschke-Ollendorff Syndrome Market growth is projected to reach USD 820.55 Billion, at a 5.48% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report...
www.marketresearchfuture.com
January 3, 2026 at 11:54 AM
yuvip.bsky.social
👁️ Achromatopsia Treatment innovations aim to improve vision in rare eye disorders. 🔬📈 www.marketresearchfuture.com/reports/achr... #Ophthalmology #RareDiseases #MedicalResearch
Achromatopsia Treatment Market Size, Share, Trends, 2035
Achromatopsia Treatment Market share is projected to reach USD 3.87 Billion By 2035, at a 11.62 % CAGR by driving industry size, top company analysis, segments research, trends and forecast report 202...
www.marketresearchfuture.com
January 3, 2026 at 11:54 AM
yuvip.bsky.social
🦠 Acanthocheilonemiasis Treatment focuses on managing rare parasitic infections. 🌍💊 www.marketresearchfuture.com/reports/acan... #RareDiseases #InfectiousDiseases #Pharma
Acanthocheilonemiasis Treatment Market Report, 2035
Acanthocheilonemiasis Treatment Market growth is projected to reach USD 551.17 Billion, at a 7.32% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast re...
www.marketresearchfuture.com
January 3, 2026 at 11:54 AM
hemehub.bsky.social
💡Today's question! A young patient with pancytopenia and congenital findings suggestive of a #genetic disorder had a negative blood chromosomal breakage test. What is the most appropriate next step?

See the answer and explanation on the next slide!

#IBMFS #Hematology #BMF #RareDiseases #HemeHub
January 2, 2026 at 10:52 PM
hemehub.bsky.social
🩸🧬 Facts about Inherited Bone Marrow Failure Syndromes: how disruptions in core cellular pathways lead to marrow failure, cancer predisposition, and multi-system disease.

#IBMFS #InheritedBoneMarrowFailure #BoneMarrowFailure #Hematology #MedEd #RareDiseases #BloodDisorders #HemeHub
January 2, 2026 at 10:51 PM
realised-ihi.bsky.social
🌟 Happy New Year from Realised Project! In 2026, we continue advancing our goal of reimagining how clinical trials for (ultra) rare diseases are designed and conducted!

#NewYear #RareDiseases #Innovation
January 2, 2026 at 2:03 PM
cnag-eu.bsky.social
🎉 ERDERA’s Joint Transnational Call 2025 results are out! 1⃣8⃣ projects selected, representing ~€29 million in funding for preclinical rare disease research

🩵 Proud partners of @erdera.bsky.social, advancing #RareDiseases

👉 Discover the selected projects here: erdera.org/news/erdera-...
#HorizonEU
ERDERA announces first Joint Transnational Call 2025 portfolio of preclinical therapy projects for rare diseases - ERDERA
Eighteen international pre clinical therapy projects selected under ERDERA’s first Joint Transnational Call will accelerate treatment options for people living with rare diseases across Europe and…
erdera.org
January 2, 2026 at 8:41 AM
yuvip.bsky.social
Novel therapies and increased awareness are shaping Spain’s myelodysplastic syndrome drugs market 👉 www.marketresearchfuture.com/reports/spai...
#Hematology #RareDiseases
Spain Myelodysplastic Syndrome Drugs Market Overview 2035
Spain Myelodysplastic Syndrome Drugs Market share register 106.82 USD Million in 2024, projected to grow 6.11 % CAGR to reach USD Million 205.02 during the forecast period 2025 - 2035.
www.marketresearchfuture.com
January 2, 2026 at 5:41 AM
yuvip.bsky.social
Improved neurological diagnostics are increasing awareness of meralgia paresthetica in the US 👉 www.marketresearchfuture.com/reports/us-m...
#Neurology #RareDiseases
US Meralgia Paresthetica Market Overview and Statistics 2035
US Meralgia Paresthetica Market share register 50.40 USD Million in 2024, projected to grow 5.89 % CAGR to reach USD Million 94.59 during the forecast period 2025 - 2035.
www.marketresearchfuture.com
January 2, 2026 at 5:41 AM
jardinjointaction.bsky.social
🎉 Happy New Year from #JARDIN!

Two years of Europe-wide collaboration, working towards improvements for people with #RareDiseases or complex conditions. In 2026, we’ll keep strengthening cooperation to benefit patients and health systems.

Wishing you a peaceful, healthy, and hopeful year ahead! ✨
January 1, 2026 at 4:31 PM
novogene-europe.bsky.social
Advance your #genomics research with our #WholeGenomeSequencing services. From cancer studies to #populationgenetics, our cutting-edge technology and #bioinformatics solutions deliver precision and actionable insights.

Learn more: https://bit.ly/3VHojph

#CancerResearch #RareDiseases
January 1, 2026 at 8:05 AM
drtimos.bsky.social
🧬 Gene & Cell Therapy | #RareDiseases 🚀
#LucidQuest delivers sharp insights to help biotechs, investors & BD teams stay ahead in fast-moving markets.
📩 info@lqventures.com or http://dlvr.it/TQ5HJL
#GeneTherapy #CellTherapy #Biotech #DueDiligence #InvestmentInsights
Gene & Cell Therapy and Rare Diseases' Research - LucidQuest Ventures
Strategic Insights and Consulting to Win in Gene & Cell Therapy and Rare Diseases
dlvr.it
December 31, 2025 at 3:58 PM
genesprouttest.bsky.social
As we head into a new year, many families set health goals. Genetic insights can help guide nutrition, activity, and wellness planning—tailored to your child.

#NewYearWellness #HealthyHabits #FamilyHealth #GeneticTesting #Genetics #Health #Child #Pediatrics #Newborn #RareDiseases #Prevention
December 30, 2025 at 1:35 PM